Biomarin Pharmaceutical (BMRN) Stock
Biomarin Pharmaceutical (BMRN) closed at $58.51 on Nov 17, 2026; its Tenet Score is 43 of 100 against 340 Healthcare peers.
6 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $58.51
- Nov 17, 2026
- Market cap
- $11.2B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 49.26 – 70.98
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 43/100
- Weak · 340 Healthcare peers
Industry: Drugs
Biomarin Pharmaceutical Inc. scores 43/100. Weak. Financial health is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ~ Piotroski F-Score
- ✕ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Quality Compounder
13F flows & insider trades land here.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysacchar…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Elanco Animal Health IncELAN | 37 | $13.2B |
| Dr. Reddy's Laboratories Ltd.RDY | 45 | $12.3B |
| Bio-Techne CorpTECH | 51 | $11.4B |
| Halozyme Therapeutics Inc.HALO | 71 | $11.0B |
| Kymera Therapeutics IncKYMR | 41 | $10.7B |
| Repligen Corp.RGEN | 49 | $10.4B |
| Madrigal Pharmaceuticals IncMDGL | 32 | $9.8B |
| TG Therapeutics IncTGTX | 43 | $9.6B |
| Spyre Therapeutics Inc.SYRE | 43 | $9.4B |
| Krystal Biotech IncKRYS | 66 | $8.8B |
Common questions
What sector and industry is Biomarin Pharmaceutical in?
Biomarin Pharmaceutical is in the Healthcare sector and the Drugs industry.
What is Biomarin Pharmaceutical's Tenet Score?
Biomarin Pharmaceutical's Tenet Score is 43 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




